Breaking News Headlines Today | Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

medtechdive.com image

News from medtechdive.com

The Ground News media bias check for medtechdive.com is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

medtechdive.com’s aggregated factuality score is High. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about medtechdive.com

Where is medtechdive.com located?medtechdive.com's Website

Media Bias Ratings

Average Bias Rating:

Center

Center

byMedia Bias/Fact Check

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top medtechdive.com News

Trump announces extra 100% tariff on China imports, adds export controls on ‘critical software’ — DAN KITWOODNICHOLAS KAMM/POOL/AFP/AFP via Getty Images via Getty Images

Trade War · United States

Trump announces extra 100% tariff on China imports, adds export controls on ‘critical software’

47% Center coverage: 306 sources

J&J to Spin Off Orthopaedics Unit After Strong Q3 Results, Stock Falls 1%

Wall Street · New Brunswick

J&J to Spin Off Orthopaedics Unit After Strong Q3 Results, Stock Falls 1%

46% Center coverage: 11 sources

J&J Chief Financial Officer Joseph Wolk explained that whilst DePuy Synthes is ‘still a great business’, it is not as fast-growing or as profitable as other core operations See the Story

Cybersecurity Triggers Another Recall of J&J’s Impella Heart Pump Controller

Johnson & Johnson · United States

Cybersecurity Triggers Another Recall of J&J’s Impella Heart Pump Controller

100% Center coverage: 1 sources

While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious injury or death.See the Story

Breaking News Topics Related to medtechdive.com